Synthesis and preliminary biological evaluation of β-carotene and retinoic acid oxidation products

Bioorganic and Medicinal Chemistry

Volumn 14, Issue 23, 2006, Pages 7875-7879

  Kithsiri Wijeratne, E M ^a   Liu, Manping X ^a,b   Kantipudi, Narendra B ^a,b   Brochini, Claudia B ^a,b   Leslie Gunatilaka, A A ^a   Canfield, Louise M ^b  

^a School of Natural Resources and the Environment   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Carotene; DACE; Oxidation products; Retinoic acid; Synthesis

Indexed keywords

BETA CAROTENE; RETINOIC ACID DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CHEMICAL BOND; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; METHYLATION; OXIDATION;

ANTINEOPLASTIC AGENTS; BETA CAROTENE; CELL LINE, TUMOR; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; NORISOPRENOIDS; OXIDATION-REDUCTION; PHOTOCHEMISTRY; STRUCTURE-ACTIVITY RELATIONSHIP; TRETINOIN;

EID: 33750085044     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2006.07.057     Document Type: Article

References (26)

1. Krinsky N.I. Anticarcinogenic activities of carotenoids in animals and cellular systems. In: Emerit I., and Chance B. (Eds). Free Radicals and Aging (1992), Birkhauser, Basel 227-234
2. Mayne S.T. FASEB. J. 10 (1996) 690-701
3. The alpha-tocopherol, beta-carotene cancer prevention study group. N. Engl. J. Med. 330 (1994) 1029-1035
4. Omaye S.T., Krinsky N.I., Kagan V.E., Mayne S.T., Liebler D.C., and Bidlack W.R. Fundam. Appl. Toxocol. 40 (1997) 163-174
5. Perocco P., Paolini M., Mazzullo M., Biagi G.L., and Cantell-Forti G. Mutat. Res. 440 (1999) 83-90
6. Lotan R. J. Natl. Cancer Inst. 91 (1999) 7-9
7. Krinsky N.I. Pure Appl. Chem. 51 (1979) 649-660
8. Mathews-Roth M.M. Biochimie 68 (1986) 875-884
9. Krinsky N.I. Free Radical Biol. Med. 7 (1989) 617-635
10. Hu X., White K.M., Jacobsen N.E., Mangelsdorf D.J., and Canfield L.M. J. Nutr. Biochem. 9 (1998) 567-574
11. Barua A.B., and Olsen J.A. J. Nutr. 130 (2000) 1996-2001
12. Njar V.C.O., Gediya L., Purushottamachar P., Chopra P., Vasaitis T.S., Khandelwal A., Mehta J., Huynh C., Belosay A., and Patel S. J. Bioorg. Med. Chem. 14 (2006) 4323-4340
13. Hansen L.A., Sigman C.C., Andreola F., Ross S.A., Kelloff G.J., and De Luca L.M. Carcinogenesis 21 (2000) 1271-1279
14. Zhang D., Holmes W.F., Wu S., Soprano D.R., and Soprano J.K. J. Cell. Physiol. 185 (2000) 1-20
15. Van Heusden J., Wouters W., Ramaekers F.C.S., Krekels M.D.W.G., Dillen L., Borgers M., and Smets G. Br. J. Cancer 77 (1998) 26-32
16. Schwartz E.L., Hallam S., Gallagher R.E., and Wiernik P.H. Biochem. Pharmacol. 50 (1995) 923-928
17. Tsamboas D., and Orfanos C.E. Pharmacol. Ther. 14 (1981) 355-374
18. Roberts A.B., and Sporn M.B. In: Sporn M.B., Roberts A.B., and Goodwin D.S. (Eds). The Retinoids vol. 2 (1984), Academic Press, Orlando, CA 120
19. Ranalder V.B., Lausecker B.B., and Huselton C. J. Chromatogr. 617 (1993) 129-135
20. Manzano V.M., Munoz J.C., Jimenez J.R., Puyol M.R., Puyol D.R., Kitamura M., and Cazana F.J. Br. J. Pharmacol. 131 (2000) 1673-1683
21. Mathew J.S., and Sharma R.P. Int. J. Immunopharmacol. 22 (2000) 693-706
22. Oyler A.R., Motto M.G., Naldi R.E., Facchine K.L., Hamburg P.F., Burinsky D.J., Dunphy R., and Cotter M.L. Tetrahedron 45 (1989) 7679-7694
23. Wade A., Hiriashi S., Takamura N., Date T., Aoe K., and Ito M.A. J. Org. Chem. 62 (1997) 4343-4348
24. Lerner D.A., Mani J.C., and Mousseron-Canet M. Bull. Soc. Chim. Fr. (1970) 1968-1974
25. Humphries K.A., and Curley Jr. R.W. Pharm. Res. 8 (1991) 826-831
26. Rubinstein L.V., Shoemaker R.H., Paul K.D., Simon R.M., Tosini S., Skehan P., Scudiero D.A., Monks A., and Boyd M.R. J. Nat. Cancer. Inst. 82 (1990) 1113-1118